Back to search results

EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Axial Spondyloarthritis (AxSpA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of the Sunshine Coast (UniSC), Birtinya, Australia

  • University of the Sunshine Coast (UniSC), Morayfield, Australia

  • The Colin Bayliss Research and Teaching Unit, Perth, Australia

  • Pioneer Clinical Research, Sydney, Australia

  • University Ghent, Ghent, Belgium

  • UZ Leuven, Leuven, Belgium

  • Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Bochum, Germany

  • Universitätsklinikum Erlangen - Medizinische Klinik 3, Erlangen, Germany

  • Amsterdam University Medical Center, Amsterdam, Netherlands

  • Leids Universitair Medisch Centrum (LUMC) (Leiden University Medical Center), Leiden, Netherlands

  • Malopolskie Badania Kliniczne (MBK Clinic), Krakow, Małopolska, Poland

  • ETG Lublin, Lublin, Poland

  • Reumedika, Poznan, Poland

  • La Paz University Hospital, Madrid, Fuencarral-El Pardo, Spain

  • Reina Sofia University Hospital, Córdoba, Poniente Sur, Spain

  • University hospital Parc Tauli de Sabadell, Sabadell, Spain

View source on ClinicalTrials.gov(opens in a new tab)